Virbac Corporation FDA Inspection Record

FEI 1944921 · Inspections, Form 483s, warning letters and import refusals

Virbac Corporation is an FDA-registered facility (FEI 1944921) located in Bridgeton, MO, US. Registered operations: ANALYSIS; LABEL; MANUFACTURE; PACK; RELABEL; REPACK. RegDataLab tracks 10 FDA inspections and 2 compliance actions at this facility.

What FDA found at this site

Latest inspection
Jun 3, 2026: No Action Indicated (NAI)
Inspections on record
10 (1 OAI, 6 VAI, 3 NAI)
Last OAI inspection
Dec 30, 2014
Warning letters
2 listed by FDA for this FEI, latest Dec 18, 2015
Recalls as the recalling firm
10, latest Apr 3, 2025
Import refusals
1

A Form 483 lists an inspector's observations. OAI means FDA recommends regulatory and/or administrative action. A warning letter is FDA's formal enforcement notice. No record here does not establish that a site is safe. Check this site on FDA's Data Dashboard.

Inspections and what FDA cited

Newest first. Citations are the inspector observations FDA publishes for the inspection.

DateResultWhat FDA cited
Jun 3, 2026No Action Indicated (NAI)No citations listed
Jan 22, 2026Voluntary Action Indicated (VAI)No citations listed
Jul 28, 2023Voluntary Action Indicated (VAI)No citations listed
Nov 25, 2019Voluntary Action Indicated (VAI)No citations listed
Mar 22, 2018No Action Indicated (NAI)No citations listed
Sep 7, 2016Voluntary Action Indicated (VAI)No citations listed
Dec 30, 2014Official Action Indicated (OAI)Cleaning / Sanitizing / Maintenance (21 CFR 211.67(a))
Written procedures not established/followed (21 CFR 211.67(b))
Calibration/Inspection/Checking not done (21 CFR 211.68(a))
Absence of Written Procedures (21 CFR 211.100(a))
and 22 more
Feb 21, 2013Voluntary Action Indicated (VAI)Examinations documented (21 CFR 211.134(c))
Investigations of discrepancies, failures (21 CFR 211.192)
Control procedures to monitor and validate performance (21 CFR 211.110(a))
Scientifically sound laboratory controls (21 CFR 211.160(b))
Nov 3, 2010Voluntary Action Indicated (VAI)Inadequate number of personnel (21 CFR 211.25(c))
Rejecting When Specifications Not Met (21 CFR 211.84(e))
Failing drug products not rejected (21 CFR 211.165(f))
Sep 23, 2009No Action Indicated (NAI)No citations listed

Recalls

Newest first. Recalls FDA's Enforcement Report lists with this FEI as the recalling firm. The recalling firm is not always the site that made the product. Search FDA's Enforcement Report by recall number.

DateClassRecallProduct and reason
Apr 3, 2025Class IIV-0071-2025Durvet Triple Wormer Flavored Chewables, 114 mg Pyrantel Pamoate, 114 mg Praziquantel… and 1 more product
Failed to meet the hardness specification during stability testing.
May 10, 2023Class IIIV-0121-2023Iverhart Max Chew (ivermectin/pyrantel pamoate/praziquantel), 6 chews per carton…
Failed to meet the average chew weight specification during stability testing.
Feb 17, 2021Class IIV-0089-20217 Way De-Wormer for Dogs, (114 mg pyrantel pamoate, 114 mg praziquantel), Greater than 25… and 3 more products
Tablets failed hardness specification at the 3 month stability time point.
Aug 31, 2016Class IIIV-0038-2017RILEXINE (cephalexin) Chewable Tablets 150 mg, 100 Tablets, NDC 051311-026-10, NADA #… and 2 more products
Labeling Defects: missing label, double label, missing lot/expiration, partial or illegible lot/expiration date. The same lots may contain…
Aug 9, 2013Class IIIV-002-2014Virbac Iverhart Plus (ivermectin/pyrantel) Flavored Chewables, 136 mcg Ivermectin and 114… and 2 more products
The products were identified during an ongoing investigation and testing as being out-of-specification for Ivermectin potency.
Mar 26, 2013Class IIIV-211-2013Ivermectin/pyrantel flavored chewables for dogs up to 25 lbs., each tablet contains 68… and 4 more products
Firm testing found recalled lots to be out of specification with sub-potent results.
Mar 26, 2012Class IIIV-088-2012Virbac IVERHART MAX (ivermectin/pyrantel pamoate/praziquantel), Chewable Tablets for Dogs…
Stability failure (low) at 9-month test interval
Dec 7, 2010Class IIV-394-2011Virbac Animal Health Soloxine (levothyroxine sodium) Tablets, 0.2 mg., packaged in… and 2 more products
The product lots were not rejected after failing to meet established specifications
Oct 19, 2010Class IIIV-093-2011Virbac Animal Health Pyoben Medicated Shampoo for Dogs, Cats and Horses, containing… and 1 more product
Some bottles of medicated shampoo were mislabeled as containing a different type of medicated shampoo
Aug 13, 2009Class IIV-272-2009Heartworm and worm prevention/control chewable tablets, containing 272 mcg. ivermectin and…
Stability failure (low) at 3-month testing interval

FDA record score

16 of 100. A count of this site's adverse public FDA records, weighted by how recent each one is. A higher number means more, or more recent, records. Each record below adds the points shown.

Counted on Nov 17, 2026, method version 1. It counts records and does not judge the site: a low number does not establish that a site is safe, and sites that FDA inspects more often can collect more points. How this is counted.

13 records behind this number
RecordDatePoints x age weightAdds
Inspection classified VAIJan 22, 20266 x 16
Class II recall V-0071-2025, this FEI as the recalling firmApr 3, 20254 x 14
Inspection classified VAIJul 28, 20236 x 0.63.6
Inspection classified VAINov 25, 20196 x 0.251.5
Class II recall V-0089-2021, this FEI as the recalling firmFeb 17, 20214 x 0.251
Inspection classified VAISep 7, 201610 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsDec 18, 201510 years or older, so it adds no points0
Inspection classified OAIDec 30, 201410 years or older, so it adds no points0
Inspection classified VAIFeb 21, 201310 years or older, so it adds no points0
Class II recall V-394-2011, this FEI as the recalling firmDec 7, 201010 years or older, so it adds no points0
Inspection classified VAINov 3, 201010 years or older, so it adds no points0
Class II recall V-272-2009, this FEI as the recalling firmAug 13, 200910 years or older, so it adds no points0
Warning letter on FDA's dashboard, which does not show close-outsDec 10, 200810 years or older, so it adds no points0

When each source was last refreshed

FDA sources behind this page and when RegDataLab last refreshed each one
RecordsLast refreshedSource as ofStatus
InspectionsNov 17, 2026Newest record Nov 9, 2026Current
Inspection citationsNov 17, 2026Newest record Nov 5, 2026Current
Compliance actions (warning letters, injunctions and other action types)Nov 2, 2026Newest record Oct 29, 2026Current
Warning letter textNov 17, 2026Newest record Nov 10, 2026Current
Recalls (Enforcement Report)Nov 17, 2026Newest record Nov 11, 2026Current
Form 483s and inspection documentsNov 17, 2026Newest record Nov 16, 2026Current
Import refusalsNov 15, 2026Newest record Nov 5, 2026Current

Reviewing Virbac Corporation as a supplier? Request a free FDA snapshot: name up to five suppliers and get a PDF of their public FDA record, with sources and dates. You do not need an API connection. Each snapshot is prepared by hand.

Check this supplier

Or check Virbac Corporation yourself in Claude, Cursor or ChatGPT: get the full FDA risk summary, with inspections, warning letters, Form 483s and import alerts by site.

Get a free API key

Facility details

Company
Virbac Corporation
Location
Bridgeton, MO (US)
Registration Expires
Dec 31, 2026
Operations
ANALYSIS; LABEL; MANUFACTURE; PACK; RELABEL; REPACK
Source
decrs

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.